Forest Infasurf NME Designation Is Independent Of Orphan Status - FDA
Executive Summary
FDA is counting Forest Pharmaceutical's Infasurf (calfactant) calf lung surfactant as a "1S" approval for 1997, despite ruling that the product cannot be marketed until the orphan drug exclusivity for Abbott's Survanta expires.